Anticipated uses: Obesity management (with or without diabetes) Type 2 diabetes Fatty liver disease (potentially pending NASH approval) Retatrutide vs Tirzepatide: Summary Comparison Conclusion Tirzepatide has changed the game in obesity and diabetes carebut retatrutide is poised to redefine the future of metabolic medicine
Presented for research literature review only Lincoff AM et al
Weight loss is a complex journey
In Korea, every job for women wants every inch of your photo to be tuned, like a work of art, she said
And for many, they delivered: 10%, 15%, or even 20% body weight lost Lower glucose, blood pressure, and inflammation Fewer heart attacks, as seen in the SELECT trial It felt like medicine had cracked the metabolic code
For Hashimoto's patients exploring GLP-1 options, having reliable, evidence-based resources is the difference between informed decision-making and risky guesswork